Mary Mantock

Mary Mantock is an accomplished regulatory affairs professional with extensive experience in oncology drug development strategies, particularly in immune-oncology and gene therapies. Currently serving as SVP Regulatory Affairs at Abivax, Mary leads a team focused on securing development strategies and ensuring submission excellence with regulatory authorities. Prior roles include Executive Director of Oncology Global Regulatory Affairs at Astellas Europe, where Mary managed global regulatory responsibilities for oncology products, and Sr Director of Regulatory Affairs at Takeda Pharmaceuticals, overseeing European and global regulatory strategy. Mary's career also includes significant contributions to Galderma R&D in managing regulatory affairs for ethical medicines in dermatology.